Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
29.5%
% of BBP's 65 holdings also in FBT
60.0%
% of FBT's 31 holdings also in BBP
Overlap by Weight
Sector Drift (BBP minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 2.1% | 2.9% | 2.1% |
|
ACADIA PHARMACEUTICALS INC | 1.9% | 3.9% | 1.9% |
|
GILEAD SCIENCES INC | 1.8% | 3.6% | 1.8% |
|
UNITED THERAPEUTICS CORP | 1.7% | 3.4% | 1.7% |
|
INTRA-CELLULAR THERAPIES INC | 1.7% | 3.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to FBT
|
MIRUM PHARMACEUTICALS, INC. | 2.4% |
|
TRAVERE THERAPEUTICS, INC. | 2.0% |
|
LIGAND PHARMACEUTICALS-CL B | 1.9% |
|
LEXICON PHARMACEUTICALS, INC. | 1.9% |
|
LEGEND BIOTECH CORPORATION SPONSORED | 1.9% |
|
BIOCRYST PHARMACEUTICALS INC | 1.8% |
|
IONIS PHARMACEUTICALS, INC. | 1.8% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | 1.8% |
|
TG THERAPEUTICS INC | 1.8% |
|
ADMA BIOLOGICS, INC. | 1.8% |
BBP Underweight Relative to FBT
|
NATERA INC | -4.3% |
|
CORCEPT THERAPEUTICS INC | -4.1% |
 |
ARGENX SE ADR | -3.8% |
|
REPLIGEN CORP | -3.8% |
|
CATALYST PHARMACEUTICAL PART | -3.6% |
|
WATERS CORP | -3.6% |
 |
ALKERMES PLC | -3.6% |
|
ILLUMINA INC | -3.3% |
|
BRUKER CORP | -3.0% |
 |
METTLER-TOLEDO INTERNATIONAL | -3.0% |